Intravenous iron and recombinant human erythropoietin in cancer patients.

Anemia/chemically induced/drug therapy; Antineoplastic Agents/adverse effects/therapeutic use; Drug Interactions; Erythropoietin, Recombinant/therapeutic use; Humans; Infusions, Intravenous; Iron/administration & dosage/adverse effects/pharmacology; Neoplasms; Quality of Life; Reproducibility of Results; Research Design

Disciplines :

Hematology

Author, co-author :

Beguin, Yves ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique

Language :

English

Title :

Intravenous iron and recombinant human erythropoietin in cancer patients.

Publication date :

2005

Journal title :

Journal of Clinical Oncology

ISSN :

0732-183X

eISSN :

1527-7755

Publisher :

American Society of Clinical Oncology, United States - Virginia

Volume :

Issue :

Pages :

651-2; author reply 652-3

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 19 February 2009

Statistics

Number of views

38 (1 by ULiège)

Number of downloads

202 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Auerbach M, Ballard H, Trout JR, et al: Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial. J Clin Oncol 22:1301-1307, 2004
Weiss G: Pathogenesis and treatment of anaemia of chronic disease. Blood Rev 16:87-96, 2002
Brugnara C, Chambers LA, Malynn E, et al: Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: Iron-deficient erythropoiesis in iron-replete subjects. Blood 81:956-964, 1993
d'Onofrio G, Chirillo R, Zini G, et al: Simultaneous measurement of reticulocyte and red blood cell indices in healthy subjects and patients with microcytic and macrocytic anemia. Blood 85:818-823, 1995
Macdougall IC, Tucker B, Thompson J, et al: A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int 50:1694-1699, 1996
Besarab A, Amin N, Ahsan M, et al: Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. J Am Soc Nephrol 11:530-538, 2000
Haurani FI, Green D, Young K: Iron absorption in hypoferremia. Am J Med Sci 249:537-547, 1965
Weinberg ED: The role of iron in cancer. Eur J Cancer Prev 5:19-36, 1996
NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 30:S192-S240, 1997 (4 suppl 3)
Drueke TB, Barany P, Cazzola M, et al: Management of iron deficiency in renal anemia: Guidelines for the optimal therapeutic approach in erythropoietin-treated patients. Clin Nephrol 48:1-8, 1997